DUOPA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Duopa, and when can generic versions of Duopa launch?
Duopa is a drug marketed by Abbvie Inc and is included in one NDA.
The generic ingredient in DUOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Duopa
A generic version of DUOPA was approved as carbidopa; levodopa by MAYNE PHARMA on August 28th, 1992.
Summary for DUOPA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Patent Applications: | 884 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DUOPA |
| What excipients (inactive ingredients) are in DUOPA? | DUOPA excipients list |
| DailyMed Link: | DUOPA at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DUOPA
US Patents and Regulatory Information for DUOPA
DUOPA is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting DUOPA
TREATMENT OF MOTOR FLUCTUATIONS IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE
Exclusivity Expiration: See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Inc | DUOPA | carbidopa; levodopa | SUSPENSION;ENTERAL | 203952-001 | Jan 9, 2015 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
